The Global Verteporfin Market Growth Accelerated By Increasing Aging Population Predisposed To AMD12/21/2023 Verteporfin, also known as Visudyne, is a light activated drug approved by the U.S. Food and Drug Administration for the treatment of wet or neovascular age-related macular degeneration (AMD). It is used along with photodynamic therapy which involves injecting verteporfin into the bloodstream and shining a special type of non-thermal laser light on the eye to seal leaky blood vessels and stop further growth/damage of abnormal blood vessels at the back of eye. This slows down the loss of central vision associated with wet AMD.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |